Boston Scientific Medsurg — Goodwill acquired decreased by 91.2% to $14.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 99.3%, from $2.15B to $14.00M. Over 4 years (FY 2021 to FY 2025), Medsurg — Goodwill acquired shows a downward trend with a -26.0% CAGR.
High values indicate active inorganic growth strategies and capital deployment into the segment.
The value of goodwill added to the MedSurg segment balance sheet during the current reporting period through business co...
Varies significantly based on M&A activity levels across the medical technology industry.
bsx_segment_medsurg_goodwill_acquired| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $578.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $374.00M | $5.00M | $731.00M | $24.00M | $0.00 | $0.00 | $2.15B | $0.00 | $0.00 | $159.00M | $14.00M |
| QoQ Change | — | — | -100.0% | — | — | — | — | — | — | -98.7% | >999% | -96.7% | -100.0% | — | — | -100.0% | — | — | -91.2% |
| YoY Change | — | — | — | — | — | -100.0% | — | — | — | — | — | — | -100.0% | -100.0% | +193.8% | -100.0% | — | — | -99.3% |